Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular access surgery: a 2-year study and comparison with the Permcath.

D A Mosquera1, S P Gibson, M D Goldman

  • 1Department of Surgery, East Birmingham Hospital, UK.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|January 1, 1992
PubMed
Summary

For hemodialysis patients, the Permcath (central venous catheter) shows comparable outcomes to secondary vascular access surgery. It may serve as a primary access option for those with limited life expectancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune biomarkers of anti-EGFR monoclonal antibody therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.

British journal of cancer·2013
Same author

The effect of age on radiocephalic fistula patency.

The journal of vascular access·2007
Same author

Endovascular treatment of arterial steal secondary to dialysis fistula.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001
Same author

Clinical application of forced oscillation.

Pulmonary pharmacology & therapeutics·2001
Same author

Prevalence and significance of thrombophilia in peripheral arterial disease.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2001

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Medical Devices

Background:

  • Vascular access is crucial for hemodialysis.
  • Traditional surgical options include arteriovenous fistulae and grafts.
  • Central venous catheters (Permcath) offer an alternative access method.

Purpose of the Study:

  • To compare the long-term efficacy and safety of primary/secondary vascular access surgery with central venous catheters (Permcath) for hemodialysis.
  • To evaluate patency rates and complication profiles of different vascular access modalities.

Main Methods:

  • A 2-year prospective study of primary and secondary vascular access surgery.
  • A retrospective study of central venous access using flexible silicone catheters (Permcath).
  • Comparison of cumulative patency and survival rates, alongside complication analysis.

Related Experiment Videos

Main Results:

  • Primary fistulae: 64.8% patency at 1 year, 57.7% at 2 years.
  • Secondary procedures: 48.1% patency at 1 and 2 years.
  • Permcath: 74% survival at 1 year, 43% at 2 years; comparable to secondary access, with lower surgical complication rates but risks of infection and bleeding.

Conclusions:

  • Permcath is a viable alternative to secondary vascular access for hemodialysis.
  • Permcath may be considered for primary access in patients with limited life expectancy.
  • Careful monitoring is needed to manage Permcath-related complications like infection and bleeding.